Product Information

TRI-LEGEST FE-28 DAY TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7697 per EA under NDC 00555903270. Its NADAC has been published 678 times since Nov 28, 2013.

FDA first approved this application on Oct 26, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TRI-LEGEST FE-28 DAY TABLET

Norethindrone Acetate and Ethinyl Estradiol
$0.7697per EA

NDC

00555903270

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076105

FDA Approved

10/26/2007

TE Code

AB

On Market Since

10/26/2007

Price Statistics

The NADAC for TRI-LEGEST FE-28 DAY TABLET has been published 678 times since Nov 28, 2013, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7697 per EA
All-time high$1.6913 (Mar 13, 2019)
All-time low$0.5989 (Jul 17, 2024)
52-week high$1.1271
52-week low$0.7339
Median price$1.1837
Average price$1.1621
Largest weekly change+48.5% (Jan 23, 2019)
Weeks tracked678
Tracking sinceNov 28, 2013

Price History

1W

+4.9%

1M

+3.2%

3M

-2.3%

6M

-8.4%

1Y

-33.3%

3Y

-32.7%

5Y

-37.4%

All

-37.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TRI-LEGEST FE-28 DAY TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TRI-LEGEST FE-28 DAY TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7697 per EA (NDC 00555903270), effective Nov 18, 2026.

How has the price of TRI-LEGEST FE-28 DAY TABLET changed over time?

Over the history we have for it, the NADAC for TRI-LEGEST FE-28 DAY TABLET has declined 37.0%. It has been tracked across 678 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TRI-LEGEST FE-28 DAY TABLET?

Since Nov 28, 2013, the NADAC for TRI-LEGEST FE-28 DAY TABLET has ranged from a low of $0.5989 (Jul 17, 2024) to a high of $1.6913 (Mar 13, 2019), with a median of $1.1837 per EA.

Are there cheaper alternatives to TRI-LEGEST FE-28 DAY TABLET?

No other NADAC-published product currently shares the active ingredient and strength of TRI-LEGEST FE-28 DAY TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TRI-LEGEST FE-28 DAY TABLET?

TRI-LEGEST FE-28 DAY TABLET (NDC 00555903270) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.